$IBO
Impact BioMedical, Inc.
XASE•Health Care•Pharmaceutical Preparations
$0.571
▲+14.74%+$0.073
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImpact BioMedical, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is IBO up today? It is at $0.571 (+14.74%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IBO spikes, and full due diligence on IBO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IBO 5 times in the last 30 days. Create a free account to track $IBO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IBO from our scanner (live price and day move above). Fresh from the SEC: IMPACT BIOMEDICAL INC. filed a Merger / acquisition communication (425). A material company disclosure like this is often the real catalyst behind a move of this size.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Macko Todd D Officer | Sold (automatic/other) | -43K 0.04% of company | sold 22% | 155K | $24K at $0.560 | Mar 27, 26 |
Macko Todd D Officer | Sold (automatic/other) | -2K | sold 0.8% | 198K | $960 at $0.600 | Mar 25, 26 |
Grady Jason Director | Sold (automatic/other) | -50K 0.05% of company | sold 17% | 250K | $33K at $0.650 | Mar 23, 26 |
Dss, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -45K 0.04% of company | n/a | n/a | $25K at $0.540 | May 27, 25 |
Dss, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -45K 0.04% of company | sold 7.7% | 545K | $25K at $0.540 | May 27, 25 |
Dss, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -116K 0.1% of company | sold 72% | 45K | $64K at $0.550 | May 22, 25 |
Dss, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -116K 0.1% of company | sold 16% | 590K | $64K at $0.550 | May 22, 25 |
Chan Heng Fai Ambrose Director | Sold (automatic/other) | -180K 0.2% of company | n/a | n/a | $173K at $0.960 | Apr 4, 25 |
Dss, Inc. Beneficial Owner (10%) | Sold (automatic/other) | -891K 0.8% of company | sold 85% | 161K | $846K at $0.950 | Apr 4, 25 |
Chan Heng Fai Ambrose Director | Sold (automatic/other) | -625K 0.6% of company | sold 78% | 180K | $362K at $0.580 | Apr 3, 25 |
Chan Heng Fai Ambrose Director | Sold (automatic/other) | -352K 0.3% of company | n/a | n/a | $172K at $0.490 | Apr 3, 25 |
Chan Heng Fai Ambrose Director | Sold (automatic/other) | -885K 0.8% of company | sold 72% | 352K | $513K at $0.580 | Apr 2, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IBO from our scanner (live price and day move above). Fresh from the SEC: IMPACT BIOMEDICAL INC. filed a Merger / acquisition communication (425). A material company disclosure like this is often the real catalyst behind a move of this size.
IBO last traded at $0.571, up 14.74% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Impact BioMedical, Inc. (IBO) is next expected to report earnings on Friday, November 6, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IBO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IBO 5 times in the last 30 days.
IBO (Impact BioMedical, Inc.) trades on XASE, with a market cap of about $54M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IBO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IBO discussion
Sign in to ask a question or join the discussion.